secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marpai, Inc. (MRAI)
CIK:        0001844392
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001213900-25-042317
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marpai appoints Dallas Scrip as COO effective June 2, 2025
----------------------------------------------------------

- Dallas Scrip appointed COO and President of MarpaiRx, effective June 2, 2025.
- Base salary $250,000; 2025 bonus up to $125k if Company profitable by year-end.
- 300,000 RSUs vesting over three years; additional 100k RSUs upon $5M EBITDA target.
- 2026 bonus tiers: up to $250k if net income $7M and revenue $100M.
- Scrip previously President of ValueHealth Benefit Administrators and Centivo.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844392/000121390025042317/0001213900-25-042317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844392/000121390025042317/ea0241792-8k_marpai.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-042317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer